N F A Peel
Overview
Explore the profile of N F A Peel including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
202
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gossiel F, Ugur A, Peel N, Walsh J, Eastell R
Osteoporos Int
. 2022 Feb;
33(6):1357-1363.
PMID: 35102444
Introduction: Bone turnover markers (BTMs) can be used to monitor response to osteoporosis treatment. However, some are affected by food intake and are not suitable to measure in a clinical...
2.
Paggiosi M, Debono M, Walsh J, Peel N, Eastell R
Osteoporos Int
. 2020 Jan;
31(4):667-675.
PMID: 31993717
Introduction: We evaluated the ability of lumbar spine bone mineral apparent density (BMAD), trabecular bone score (TBS) and volumetric bone mineral density (vBMD) to discriminate between postmenopausal women with low...
3.
Naylor K, McCloskey E, Jacques R, Peel N, Paggiosi M, Gossiel F, et al.
Osteoporos Int
. 2019 Jan;
30(4):917-922.
PMID: 30613868
Introduction: Measurement of bone turnover markers (BTMs) may be useful to monitor offset of treatment with bisphosphonates (BP) in osteoporosis. We assessed the effect of withdrawal of BP treatment by...
4.
Naylor K, Bradburn M, Paggiosi M, Gossiel F, Peel N, McCloskey E, et al.
Osteoporos Int
. 2018 Mar;
29(6):1407-1417.
PMID: 29525970
Introduction: Bisphosphonates (BPs) continue to suppress bone turnover markers (BTMs) after treatment has stopped, leading to the suggestion that a pause in treatment could be considered for low-risk patients. Indirect...
5.
Naylor K, Jacques R, Peel N, Gossiel F, Eastell R
Osteoporos Int
. 2016 Mar;
27(8):2585-92.
PMID: 27026335
Unlabelled: We used two methods of identifying women who reached the target for raloxifene treatment with bone turnover markers. Both approaches identified women that responded to treatment but did not...
6.
Naylor K, Jacques R, Paggiosi M, Gossiel F, Peel N, McCloskey E, et al.
Osteoporos Int
. 2015 May;
27(1):21-31.
PMID: 25990354
Unlabelled: We used bone turnover markers to identify women who responded to bisphosphonate treatment for osteoporosis. Response was more likely with alendronate and ibandronate than risedronate. There was a greater...
7.
Paggiosi M, Peel N, Eastell R
Osteoporos Int
. 2015 Mar;
26(6):1773-80.
PMID: 25743176
Unlabelled: We propose that trabecular bone score could be a useful tool for the study of glucocorticoid-associated bone effects. Trabecular bone score alone and lumbar spine bone mineral density (BMD)...
8.
Kuet K, Charlesworth D, Peel N
Osteoporos Int
. 2013 Jan;
24(3):1007-14.
PMID: 23306821
Unlabelled: Vertebral fracture assessment (VFA) scanning is a useful tool to aid vertebral fracture identification. In this evaluation, we show that introduction of a comprehensive fracture risk assessment pathway incorporating...
9.
Naylor K, Clowes J, Finigan J, Paggiosi M, Peel N, Eastell R
Bone
. 2009 Nov;
46(3):592-7.
PMID: 19897063
There is evidence to suggest accelerated bone loss following estrogen cessation. The effect of cessation of raloxifene therapy on bone turnover is unknown. Our aim was to determine the effect...
10.
Clowes J, Peel N, Eastell R
Osteoporos Int
. 2006 Jul;
17(9):1293-302.
PMID: 16810454
Introduction: A single T score criterion cannot be universally applied to different peripheral bone measurement devices, since measurements in an identical population result in a tenfold difference in the prevalence...